锥形束CT引导在线自适应放疗在全乳照射中的临床实施
BREAST-ART前瞻性单臂试验纳入20例术后右侧全乳照射患者(5×5.2 Gy),比较基于每日解剖计算的参考治疗计划与自适应计划的剂量学,并评估在线自适应放疗工作流程时长、满意度问卷和急性毒性。前17例(85次分次)中,CBCT1结束至CBCT3结束的床上时间为中位13.8分钟(范围11-25);对4例(20次分次)使用影响结构(即乳腺)及10例(36次分次)手动校正最头侧和最尾侧靶区轮廓(即4 mm)进行回顾性评估后,最后3例临床患者的床上时间降至中位13.0分钟(范围11-19)。未观察到3级及以上毒性,20例中19例表示愿意再次接受相同治疗,治疗期间不再需要皮肤标记定位。
要点
- 20例术后右侧全乳照射(5×5.2 Gy)患者纳入前瞻性单臂BREAST-ART试验评估在线自适应放疗可行性。
- 前17例85次分次中,CBCT1结束至CBCT3结束的床上时间为中位13.8分钟(范围11-25)。
- 未观察到3级及以上毒性,20例中19例表示愿意再次接受相同治疗。
核心结论
- 本研究展示了乳腺癌患者实施在线自适应放疗的可行性、挑战和实用解决方案。
- 未来工作将聚焦更复杂的乳腺适应证,如包括腋窝淋巴结的全乳照射,以进一步研究在线自适应放疗在乳腺癌中的获益与挑战。
研究设计与样本
- BREAST-ART为前瞻性单臂试验,纳入20例接受术后右侧全乳照射(5×5.2 Gy)的患者。
- 比较基于每日解剖计算的参考治疗计划与自适应治疗计划的剂量学。
- 收集在线自适应放疗工作流程时长、院内满意度问卷和急性毒性(美国国家癌症研究所不良事件通用术语标准v5.0)。
- 通过研究手动校正影响结构和靶区轮廓对治疗时间和质量的影响来评估在线自适应放疗工作流程。
主要发现
- 前17例(85次分次)中,CBCT1结束至CBCT3结束的床上时间为中位13.8分钟(范围11-25)。
- 对4例(20次分次)使用影响结构(即乳腺)及对10例(36次分次)手动校正最头侧和最尾侧靶区轮廓(即4 mm)进行回顾性评估后,最后3例临床患者的床上时间降至中位13.0分钟(范围11-19)。
- 未观察到3级及以上毒性,20例中19例表示愿意再次接受相同治疗。
- 治疗期间不再需要用于患者定位的皮肤标记。
临床怎么用
- 本研究中心已将在线自适应放疗临床实施于全乳照射,治疗期间不再需要皮肤标记定位。
- 作者指出未来工作将聚焦更复杂的乳腺适应证,如包括腋窝淋巴结的全乳照射,以进一步研究在线自适应放疗的获益与挑战。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: In postoperative breast irradiation, changes in the breast contour and arm positioning can result in patient positioning errors and offline replanning. This can lead to increased treatment burden and strain on departmental logistics because of the need for additional cone beam computed tomography (CBCT) images or even a new radiation therapy treatment plan (TP). Online daily adaptive radiation therapy (oART) could provide a solution to these challenges. We have clinically implemented and evaluated the feasibility of oART for whole breast irradiation. METHODS AND MATERIALS: Twenty patients treated with postoperative whole breast right irradiation (5 × 5.2 Gy) were included in BREAST-ART, a prospective single-arm trial. The dosimetry of the reference TP calculated on the daily anatomy and adaptive TP were compared. Duration of the oART workflow, in-house satisfaction questionnaires, and acute toxicity (National Cancer Institute Common Terminology Criteria for Adverse Event v5.0) were collected. The oART workflow was evaluated by investigating the impact of manual corrections of influencer and target contours on treatment time and quality. RESULTS: In the first 17 patients (85 fractions), the on-couch time, ie, the time between the end of CBCT1 and CBCT3, was a median of 13.8 minutes (range, 11-25). Retrospective evaluation of the use of the influencer (ie, breast) in 4 patients (20 fractions) and manual correction of the most cranial and caudal target contours (ie, 4 mm) in 10 patients (36 fractions) was done. This resulted in a reduced on-couch time in the last 3 clinical patients to a median of 13.0 minutes (range, 11-19). No grade 3 or higher toxicity was observed, and 19 of 20 patients indicated that they preferred the same treatment again. Skin marks for patient positioning during treatment were no longer necessary. CONCLUSIONS: This study showed the feasibility, challenges, and practical solutions for the implementation of oART for breast cancer patients. Future work will focus on more complex breast indications, such as whole breast, including axillary nodes, to further investigate the benefits and challenges of oART in breast cancer.
引用
- Nelissen KJ, Verbakel WFAR, Middelburg-van Rijn JG, et al. Clinical Implementation of Cone Beam Computed Tomography-Guided Online Adaptive Radiation Therapy in Whole Breast Irradiation. Adv Radiat Oncol. 2024. PMID: 39687477. doi:10.1016/j.adro.2024.101664
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。